Maintaining What Is Already There: Strategies to Rectify HSC Transplantation Dilemmas

Cell Stem Cell. 2015 Sep 3;17(3):258-9. doi: 10.1016/j.stem.2015.08.012.

Abstract

Hematopoietic stem cell (HSC) transplantation remains the only cure for various hematological diseases, but low HSC numbers in many donor samples are a critical problem preventing their clinical use. Now in Nature and Cell, two creative strategies to rescue and improve pre-existing engraftment potential are presented.

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • 8,11,14-Eicosatrienoic Acid / analogs & derivatives*
  • Animals
  • Bone Marrow*
  • Female
  • Fetal Blood / cytology*
  • Hematopoiesis*
  • Hematopoietic Stem Cell Transplantation*
  • Hematopoietic Stem Cells / cytology*
  • Humans
  • Male
  • Zebrafish / embryology*

Substances

  • 8,11,14-Eicosatrienoic Acid